GENE ONLINE|News &
Opinion
Blog

2020-09-27| SpecialTechnology

Combining the Power of miRNAs and Nanotechnology to Prevent Osteoarthritis Progression

by GeneOnline
Share To
miRNAs belong to the category of non-coding RNAs. They block the expression of a gene either by binding to its specific mRNA and degrading it or by preventing the translation of the specific mRNA. More than 1900 miRNAs have been discovered to date in humans, and many of them have been implicated in various human diseases. Changes in the expression of miRNA have been involved in diseases like cancer, obesity, cardiovascular diseases, and osteoarthritis (OA).
Several miRNAs have been identified that are differentially expressed in OA . One of the first miRNA that has been linked to OA pathology is miRNA-140.

GO Prime with only $1.49 now

LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
EVENT
Scroll to Top